References
- Buttacavoli, M., Di Cara, G., Roz, E., Pucci-Minafra, I., Feo, S., & Cancemi, P. (2021). Integrated multi-omics investigations of metalloproteinases in colon cancer: Focus on MMP2 and MMP9. International journal of molecular sciences, 22(22), 12389.
- Jafarian, A. H., Reisi, H., & Roshan, N. M. (2020). Matrix metalloproteinase-9 (MMP-9) expression in non-small cell lung carcinoma and its association with clinicopathologic factors. Iranian Journal of Pathology, 15(4), 326.
- Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S., & Barsouk, A. (2021). Epidemiology of lung cancer. Contemporary Oncology/Współczesna Onkologia, 25(1), 45–52.
- Januškevičienė, I., & Petrikaitė, V. (2019). Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations. Life sciences, 239, 117009.
- Venkitaraman, A. R. (2019). How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?. DNA repair, 81, 102668.
- Zhang, B., Zhang, L., Yue, D., Li, C., Zhang, H., Ye, J., ... & Wang, C. (2020). Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis. Translational Lung Cancer Research, 9(4), 1187.
- Costea, T., Vlad, O. C., Miclea, L. C., Ganea, C., Szöllősi, J., & Mocanu, M. M. (2020). Alleviation of multidrug resistance by flavonoid and nonflavonoid compounds in breast, lung, colorectal and prostate cancer. International journal of molecular sciences, 21(2), 401.
- Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020). Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. European journal of medicinal chemistry, 194, 112260.
- Niland, S., Riscanevo, A. X., & Eble, J. A. (2021). Matrix metalloproteinases shape the tumor microenvironment in cancer progression. International journal of molecular sciences, 23(1), 146.
- Huang, H. (2018). Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors, 18(10), 3249.
- Jiang, H., & Li, H. (2021). Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic review and meta-analysis. BMC cancer, 21, 1–13.
- Zhang, H., Zhao, B., Zhai, Z. G., Zheng, J. D., Wang, Y. K., & Zhao, Y. Y. (2021). Expression and clinical significance of MMP-9 and P53 in lung cancer. European Review for Medical & Pharmacological Sciences, 25(3).
- Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., ... & Martinez-Fierro, M. L. (2020). The roles of matrix metalloproteinases and their inhibitors in human diseases. International journal of molecular sciences, 21(24), 9739.
- Joseph, C., Alsaleem, M., Orah, N., Narasimha, P. L., Miligy, I. M., Kurozumi, S., ... & Rakha, E. A. (2020). Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival. Breast cancer research and treatment, 182, 267–282.
- Chien, Y. C., Liu, L. C., Ye, H. Y., Wu, J. Y., & Yu, Y. L. (2018). EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway. American journal of cancer research, 8(3), 422.
- Hamad, H. A., Enezei, H. H., Alrawas, A., Zakuan, N. M., Abdullah, N. A., Cheah, Y. K., & Hashim, N. F. M. (2020). Identification of potential chemical substrates as fuel for hypoxic tumors that may be linked to invadopodium formation in hypoxia-induced MDA-MB-231 breast-cancer cell line. Molecules, 25(17), 3876.
- Hamad, H. A., Gopalsamy, B., Kqueen, C. Y., & Hashim, N. F. M. (2019). Potential Ability of Phytochemical in Inhibition of Invadopodia Formation and HIF-1α in Cancer Metastasis. Malaysian Journal of Medicine & Health Sciences, 15.
- Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., ... & von Mering, C. (2021). The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic acids research, 49(D1), D605–D612.
- Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic acids research, 45(W1), W98–W102.
- Digre, A., & Lindskog, C. (2021). The Human Protein Atlas—Spatial localization of the human proteome in health and disease. Protein Science, 30(1), 218–233.
- Labeda, I., Uwuratuw, J. A., Hendarto, J., Lusikooy, R. E., Sampetoding, S., Kusuma, M. I., ... & Faruk, M. (2023). Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study. Annals of Medicine and Surgery, 85(9), 4277–4282.
- Chien, Y. C., Liu, L. C., Ye, H. Y., Wu, J. Y., & Yu, Y. L. (2018). EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway. American journal of cancer research, 8(3), 422.
- Joseph, C., Alsaleem, M., Orah, N., Narasimha, P. L., Miligy, I. M., Kurozumi, S., ... & Rakha, E. A. (2020). Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival. Breast cancer research and treatment, 182, 267–282.
- Tan, H., Zhang, M., Xu, L., Zhang, X., & Zhao, Y. (2022). Gypensapogenin H suppresses tumor growth and cell migration in triple-negative breast cancer by regulating PI3K/AKT/NF-κB/MMP-9 signaling pathway. Bioorganic Chemistry, 126, 105913.
- Li, C., Ma, Y., Fei, F., Zheng, M., Li, Z., Zhao, Q., ... & Zhang, S. (2020). Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases. Journal of Cancer, 11(4), 826.
- Kang, C., Wang, L., Wang, D., Zhang, X., & Chen, J. (2020). Lung cancer A549 cells suppressed with overexpressed HNF1B or PCDHA13 inhibited PI3K/AKT phosphorylation. Translational Cancer Research, 9(6), 3819.
- Peeney, D., Fan, Y., Nguyen, T., Meerzaman, D., & Stetler-Stevenson, W. G. (2019). Matrisome-associated gene expression patterns correlating with TIMP2 in cancer. Scientific reports, 9(1), 20142.
- Lu, L., Liu, Q., Wang, P., Wu, Y., Liu, X., Weng, C., ... & Liu, G. (2019). MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway. BMC cancer, 19, 1–11.
- Mao, Y., Su, C., Yang, H., Ma, X., Zhao, F., Qu, B., ... & Cui, Y. (2024). PI3K/AKT/mTORC1 signalling pathway regulates MMP9 gene activation via transcription factor NF-κB in mammary epithelial cells of dairy cows. Animal Biotechnology, 2314100.
- Wu, L., Wang, J., Zhao, J., Yao, R., Xu, Q., Ma, L., & Liu, J. (2022). Bioinformatics analysis identified RGS4 as a potential tumor promoter in glioma. Pathology-Research and Practice, 240, 154225.
- Gu, Y., Yu, J., Ding, C., Zhou, Y., Yang, J., Yu, W., ... & Huang, H. (2021). Flavonoid GL-V9 suppresses invasion and migration of human colorectal cancer cells by inhibiting PI3K/Akt and MMP-2/9 signaling. Journal of Cancer, 12(15), 4542.
- Jian, F., Yanhong, J., Limeng, W., Guoping, N., Yiqing, T., Hao, L., & Zhaoji, P. (2022). TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer. International immunopharmacology, 110, 109008.
- Costanzo, L., Soto, B., Meier, R., & Geraghty, P. (2022). The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs. Pulmonary Medicine, 2022.
- Chen, W. Q., Yang, S. J., Xu, W. X., Deng, F., Wang, D. D., & Tang, J. H. (2021). Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer. Medicine, 100(42), e27489.
- Yu, J., He, Z., He, X., Luo, Z., Lian, L., Wu, B., ... & Chen, H. (2021). Comprehensive analysis of the expression and prognosis for MMPs in human colorectal cancer. Frontiers in Oncology, 11, 771099.
- Augoff, K., Hryniewicz-Jankowska, A., Tabola, R., & Stach, K. (2022). MMP9: a tough target for targeted therapy for cancer. Cancers, 14(7), 1847.
- Rashid, Z. A., & Bardaweel, S. K. (2023). Novel matrix metalloproteinase-9 (MMP-9) inhibitors in cancer treatment. International journal of molecular sciences, 24(15), 12133.